Submitted by Anonymous (not verified) on 7 October 2026 - 12:55
Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Date of authorisation: 22/12/2014, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Date of authorisation: 22/12/2014, Revision: 14, Status: Authorised